ADGN 901
Alternative Names: ADGN-901Latest Information Update: 13 Jun 2024
At a glance
- Originator Aanastra
- Class Antineoplastics; Gene therapies; RNA
- Mechanism of Action BRCA1 protein expression modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Breast cancer